كارنيتين محلول ٣٠% Israel - arabisk - Ministry of Health

كارنيتين محلول ٣٠%

abic marketing ltd - levocarnitine 30 % - solution - levocarnitine - systemic and myopathic carnitine deficiency.

نورڤاسك ٥ ملغ Israel - arabisk - Ministry of Health

نورڤاسك ٥ ملغ

pfizer pharmaceuticals israel ltd - amlodipine as besylate 5 mg - tablets - amlodipine - mild to moderate hypertension. vasospastic angina ( prinzmetal's or variant angina). chronic stable angina.

نورڤاسك ١٠ ملغ Israel - arabisk - Ministry of Health

نورڤاسك ١٠ ملغ

pfizer pharmaceuticals israel ltd - amlodipine as besylate 10 mg - tablets - amlodipine - mild to moderate hypertension. vasospastic angina ( prinzmetal's or variant angina). chronic stable angina.

راﻣيپريل تيڤع ٥ ملغ Israel - arabisk - Ministry of Health

راﻣيپريل تيڤع ٥ ملغ

teva pharmaceutical indust.ltd - ramipril 5 mg - tablets - ramipril - - hypertension - congestive heart failure - reduction of mortality in patients after mi with left ventricular dysfunction for reducing the risk of myocardial infarction stoke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. - prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.

تريتايس كومب ٢٫٥ ملغم/١٢٫٥ ملغ Israel - arabisk - Ministry of Health

تريتايس كومب ٢٫٥ ملغم/١٢٫٥ ملغ

sanofi - aventis israel ltd - hydrochlorothiazide 12.5 mg; ramipril 2.5 mg - tablets - ramipril and diuretics - essential hypertension. tritace comp is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

ىاسمىن Israel - arabisk - Ministry of Health

ىاسمىن

bayer israel ltd - drospirenone 3 mg; ethinylestradiol 0.03 mg - film coated tablets - drospirenone and estrogen - oral contraception.

ىاز Israel - arabisk - Ministry of Health

ىاز

bayer israel ltd - drospirenone 3 mg; ethinylestradiol 0.02 mg - film coated tablets - drospirenone and estrogen - - oral contraception. - treatment of moderate acne vulgaris in women who seek oral contraception. - treatment of symptoms of premenstrual dysphoric disorder (pmdd ) in women who have chosen oral contraceptives as their method of birth control. the efficacy of yaz for pmdd was not assessed beyond 3 cycles. yaz has not been evaluated for treatment of pms ( premenstrual syndrome ).

چينوتروپين ١٢ Israel - arabisk - Ministry of Health

چينوتروپين ١٢

pfizer pharmaceuticals israel ltd - somatropin recombinant 36 iu/ml - lyophilized powder for injection - somatropin - children: short stature due to inadequate or failed secretion of pituitary growth hormone or turner`s syndrome. short stature in children with renal insufficiency. growth disturbance (height sds<2.5 and parenteral adjusted height sds < -1) in short children born sga (sga - small for gestational age i.e. born small in relation to the length of the fetus development) with a birth witght and/or length < 2 sd who failed to show catch up growth (hv sds < 0 during the last year) by 4 years of age or later. prader willi syndrome for improvement of growth and body composition. adults: for adults who have suffered from growth-hormone deficiency since childhood. for adults who have aquired growth hormone deficiency due to a pituitary pathology causing hypopituitarism.

موكسيپن فورتة ٥٠٠ ملغ Israel - arabisk - Ministry of Health

موكسيپن فورتة ٥٠٠ ملغ

salomon,levin & elstein ltd - amoxicillin trihydrate 500 mg - capsules - amoxicillin - infections caused by amoxycillin - susceptible organisms. prevention of bacteremia in patients at risk of developing bacterial endocarditis.

اموكسكلاڤ تيڤع ٨٧٥ ملغ Israel - arabisk - Ministry of Health

اموكسكلاڤ تيڤع ٨٧٥ ملغ

salomon,levin & elstein ltd - amoxicillin as trihydrate 875 mg; clavulanic acid as potassium salt 125 mg - film coated tablets - ampicillin, combinations - short-term treatment of bacterial infections at the following sites: upper/lower respiratory tract infections, genito-urinary tract infections, skin and soft tissue infections, bone and joint infections, dental infections and other infections.